Change Agents Corporation.
Close on Oct 19, 2026
- Market cap
- $21.16M
- P/E (TTM)
- –
- Dividend yield
- –
About Change Agents
Services-Computer Programming Services, SIC 7371
Avalon GloboCare Corp. is a technology-innovation company operating in two primary business segments: consumer health technology and artificial intelligence content technology. In consumer health, the company distributes the Keto Air breathalyzer, a non-invasive, reusable, FDA-registered device designed to determine nutritional ketosis levels by measuring a user's breath. In its AI content technology segment, the company develops and commercializes an AI-driven short-form video generation platform through its subsidiary, Avalon Quantum AI, LLC. The platform creates automated videos featuring personalized AI avatars that replicate the voice and likeness of content creators. The company directs its commercial sales and services toward content creators, podcasters, marketers, social media influencers, consumers, and wellness initiatives such as law enforcement personnel programs.
The company holds exclusive distribution rights for the Keto Air device across North America, covering the United States, Canada, and Mexico. Corporate headquarters are located in Freehold, New Jersey.
Summary of the business section of Change Agents's latest annual report, written by StockData.
Company profile
Company
- Legal name
- Change Agents Corporation.
- Headquarters
- Freehold, NJ
- Address
- 4400 Route 9, Suite 3100 07728
- Phone
- (732) 780-4400
- Website
- avalon-globocare.com
- Employees
- 2, Dec 31, 2025
- Industry
- Services-Computer Programming Services
- Incorporated in
- Delaware
- Fiscal year ends
- December 31
- Auditor
- M&K CPAS, PLLC, The Woodlands, TX
Stock & identifiers
- Ticker
- CHGA
- Exchange
- Nasdaq
- Shares outstanding
- 20M, Aug 10, 2026
- Public float
- $5.48M, Jun 30, 2025
- Filer category
- Non-accelerated filer<br>Smaller reporting company
- Stock splits
- 1-for-20 reverse, Aug 31, 2026; 1-for-15 reverse, Nov 12, 2024; 1-for-15 reverse, Oct 28, 2024; 1-for-10 reverse, Mar 30, 2023; 1-for-10 reverse, Jan 5, 2023; 57-for-2, Mar 28, 2017; 1-for-4 reverse, Nov 7, 2016
- SEC CIK
- 1630212
- CUSIP
- 05344R302
- ISIN
- US05344R3021
- EIN
- 47-1685128
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Meng Li | Interim CEO | 5,150,000 |
| Luisa Ingargiola | Chief Strategy Officer | – |
| Michael Mathews | Director | 62,280 |
| Steven Andrew Sanders | Director | – |
| Lourdes Felix | Director | – |
| Wenzhao Lu | Director | 35,837,869 |
CEO pay and shareholder return
Pay versus performance table from the proxy statement
| Fiscal year | CEO total pay | CEO pay actually paid | Other executives (avg) | Value of $100 invested | Peer group |
|---|---|---|---|---|---|
| FY2025 David Jin | $14.17K | – | $351.26K | $2 | – |
| FY2024 David Jin | $180.00K | $180.00K | $277.74K | $4 | – |
| FY2023 David Jin | $330.00K | $330.00K | $315.12K | $9 | – |
“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.
Employees
Headcount reported in annual reports
“As of March 25, 2026, we employed two full time employees and several independent contractors.”
Corporate history
Events identified from SEC filings